Skip to main content

Ocular Therapeutix, Inc

OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001393434

In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

13F holders, Q4 2025

Institutional positions in Ocular Therapeutix, Inc as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
249
+39 vs. Q3 2025
Shares held
191.6M
+4.33M (+2.3%) vs. Q3 2025
Total value
$2.33B
+$136.3M (+6.2%) vs. Q3 2025
New holders
59
103 more added
Sold out
20
61 more reduced

6 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting OCUL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 249 institutions
Q1 2021: 154 institutionsQ2 2021: 149 institutionsQ3 2021: 141 institutionsQ4 2021: 140 institutionsQ1 2022: 132 institutionsQ2 2022: 123 institutionsQ3 2022: 130 institutionsQ4 2022: 116 institutionsQ1 2023: 127 institutionsQ2 2023: 135 institutionsQ3 2023: 114 institutionsQ4 2023: 119 institutionsQ1 2024: 147 institutionsQ2 2024: 151 institutionsQ3 2024: 168 institutionsQ4 2024: 180 institutionsQ1 2025: 197 institutionsQ2 2025: 187 institutionsQ3 2025: 216 institutionsQ4 2025: 249 institutionsQ1 2026: 271 institutionsQ2 2026: 262 institutions
Value heldQ4 2025: $2.33B
Q1 2021: $774.9MQ2 2021: $685.8MQ3 2021: $445.7MQ4 2021: $289.1MQ1 2022: $215.4MQ2 2022: $178.2MQ3 2022: $177.6MQ4 2022: $111.3MQ1 2023: $213.8MQ2 2023: $224.2MQ3 2023: $127.0MQ4 2023: $328.8MQ1 2024: $1.12BQ2 2024: $939.8MQ3 2024: $1.22BQ4 2024: $1.14BQ1 2025: $1.01BQ2 2025: $1.45BQ3 2025: $2.20BQ4 2025: $2.33BQ1 2026: $1.77BQ2 2026: $2.03B
Institutions holding OCUL and their total value by quarter
QuarterHoldersValue
Q2 2026262$2.03B
Q1 2026271$1.77B
Q4 2025249$2.33B
Q3 2025216$2.20B
Q2 2025187$1.45B
Q1 2025197$1.01B
Q4 2024180$1.14B
Q3 2024168$1.22B
Q2 2024151$939.8M
Q1 2024147$1.12B
Q4 2023119$328.8M
Q3 2023114$127.0M
Q2 2023135$224.2M
Q1 2023127$213.8M
Q4 2022116$111.3M
Q3 2022130$177.6M
Q2 2022123$178.2M
Q1 2022132$215.4M
Q4 2021140$289.1M
Q3 2021141$445.7M
Q2 2021149$685.8M
Q1 2021154$774.9M

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Ocular Therapeutix, Inc; share changes are against Q3 2025.

Institutions holding OCUL in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Knoll Capital Management, LLC600,400$7.28M3.34%00.0%Unchanged
Bank of America Corp601,360$7.30M0.00%+154,244+34.5%Added
Citigroup Inc601,917$7.31M0.00%−71,431−10.6%Reduced
Assenagon Asset Management S.A.620,814$7.54M0.01%+575,214+1,261.4%Added
Defilade Capital Management, L.P.681,663$8.28M1.12%+681,663New
Catalio Capital Management, LP714,501$8.67M1.53%+714,501New
Cetera Investment Advisers722,540$8.77M0.01%+8,474+1.2%Added
Balyasny Asset Management LLC763,559$9.27M0.02%−1,425,717−65.1%Reduced
Qube Research & Technologies Ltd769,774$9.35M0.01%+738,922+2,395.1%Added
Spruce Street Capital LP783,999$9.52M3.14%+783,999New
Renaissance Technologies LLC791,200$9.61M0.01%+791,200New
Voloridge Investment Management, LLC812,078$9.86M0.03%+812,078New
Candriam Luxembourg S.C.A.841,602$10.2M0.05%+841,602New
Raymond James Financial Inc842,187$10.2M0.00%−169,782−16.8%Reduced
Barclays PLC857,649$10.4M0.00%+446,032+108.4%Added
Morgan Stanley879,144$10.7M0.00%−1,586,532−64.3%Reduced
Invesco Ltd.895,687$10.9M0.00%−148,209−14.2%Reduced
Point72 Asset Management, L.P.1,016,248$12.3M0.02%−3,585,073−77.9%Reduced
Jane Street Group, LLC1,034,229$12.6M0.01%+680,417+192.3%Added
Acuta Capital Partners, LLC1,052,995$12.8M8.68%−112,211−9.6%Reduced
Artisan Partners Limited Partnership1,063,371$12.9M0.02%−13,011−1.2%Reduced
D. E. Shaw & Co., Inc.1,153,910$14.0M0.01%+1,040,631+918.6%Added
UBS Group AG1,244,944$15.1M0.00%−3,322−0.3%Reduced
Marshall Wace, LLP1,377,203$16.7M0.02%−224,246−14.0%Reduced
Charles Schwab Investment Management Inc1,460,457$17.7M0.00%+336,354+29.9%Added
Northern Trust Corp1,462,503$17.8M0.00%+287,169+24.4%Added
Saturn V Capital Management LLC1,504,880$18.3M3.35%+353,194+30.7%Added
Goldman Sachs Group Inc1,547,523$18.8M0.00%+751,555+94.4%Added
Opaleye Management Inc.1,595,000$19.4M2.55%00.0%Unchanged
Woodline Partners LP1,666,136$20.2M0.08%+490.0%Added
Citadel Advisors LLC2,475,849$30.1M0.02%−3,227,932−56.6%Reduced
Deltec Asset Management LLC2,487,934$30.2M5.00%−274,525−9.9%Reduced
Octagon Capital Advisors LP2,623,600$31.9M3.99%−4000.0%Reduced
Paradigm Biocapital Advisors LP2,935,284$35.6M0.95%−562,023−16.1%Reduced
Millennium Management LLC3,207,881$38.9M0.03%−647,825−16.8%Reduced
Logos Global Management LP3,500,000$42.5M2.83%+250,000+7.7%Added
State Street Corp4,196,330$50.9M0.00%+736,318+21.3%Added
Janus Henderson Group PLC4,229,202$51.3M0.02%+2,180,702+106.5%Added
Alliancebernstein L.P.4,341,951$52.7M0.02%+917,512+26.8%Added
Geode Capital Management, LLC4,356,547$52.9M0.00%+1,018,094+30.5%Added
Adage Capital Partners GP, L.L.C.4,625,050$56.1M0.08%+620,700+15.5%Added
TCG Crossover Management, LLC5,740,231$69.7M2.31%−377,001−6.2%Reduced
VR Adviser, LLC7,315,547$88.8M4.39%−5,845,915−44.4%Reduced
Deep Track Capital, LP8,070,414$98.0M2.23%−3,861,723−32.4%Reduced
Avoro Capital Advisors LLC10,777,777$130.8M1.29%+527,777+5.1%Added
Summer Road LLC11,108,555$134.9M97.92%−1,471,102−11.7%Reduced
Vanguard Group Inc11,575,193$140.5M0.00%+2,411,953+26.3%Added
BlackRock, Inc.15,602,394$189.4M0.00%+5,045,557+47.8%Added
FMR LLC31,785,605$385.9M0.02%−290.0%Reduced
Eventide Asset Management, LLC0$00.00%−598,000−100.0%Sold out
Driehaus Capital Management LLC0$00.00%−518,754−100.0%Sold out
Centiva Capital, LP0$00.00%−250,000−100.0%Sold out
Affinity Asset Advisors, LLC0$00.00%−239,000−100.0%Sold out
Cantor Fitzgerald, L. P.0$00.00%−201,865−100.0%Sold out
Macquarie Group Ltd0$00.00%−174,389−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−163,132−100.0%Sold out
Maven Securities LTD0$00.00%−100,000−100.0%Sold out
Hudson Bay Capital Management LP0$00.00%−50,039−100.0%Sold out
Harbert Fund Advisors, Inc.0$00.00%−50,000−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−17,088−100.0%Sold out
Levin Capital Strategies, L.P.0$00.00%−15,000−100.0%Sold out
Vontobel Holding Ltd.0$00.00%−14,498−100.0%Sold out
Dudley & Shanley, Inc.0$00.00%−13,000−100.0%Sold out
Axq Capital, LP0$00.00%−11,517−100.0%Sold out
Marex Group plc0$00.00%−10,000−100.0%Sold out
Quarry LP0$00.00%−6,870−100.0%Sold out
Advisory Services Network, LLC0$00.00%−636−100.0%Sold out
Bessemer Group Inc0$00.00%−151−100.0%Sold out
Clearstead Advisors, LLC0$00.00%−35−100.0%Sold out
Cubist Systematic Strategies, LLC––––Not filed
AXA Investment Managers S.A.––––Not filed
Point72 (DIFC) Ltd––––Not filed
CIBC Bancorp USA Inc.––––Not filed
Point72 Europe (London) LLP––––Not filed
Point72 Asia (Singapore) Pte. Ltd.––––Not filed